Baby Safety / Compounds / Decabromodiphenyl ether (DecaBDE / BDE-209)

Is Decabromodiphenyl ether (DecaBDE / BDE-209) safe for babies and kids?

Elevated risk for kids

Infants face disproportionate exposure to Decabromodiphenyl ether (DecaBDE / BDE-209) through dust ingestion (hand-to-mouth behavior), breast milk transfer, and dermal contact with treated textiles in cribs and car seats.

What is decabromodiphenyl ether (decabde / bde-209)?

The IUPAC name is 1,2,3,4,5-pentabromo-6-(2,3,4,5,6-pentabromophenoxy)benzene.

Also known as: 1,2,3,4,5-pentabromo-6-(2,3,4,5,6-pentabromophenoxy)benzene, Decabromodiphenyl ether, Decabromodiphenyl oxide, Pentabromophenyl ether.

IUPAC name
1,2,3,4,5-pentabromo-6-(2,3,4,5,6-pentabromophenoxy)benzene
CAS number
1163-19-5
Molecular formula
C12Br10O
Molecular weight
959.2 g/mol
SMILES
C1(=C(C(=C(C(=C1Br)Br)Br)Br)Br)OC2=C(C(=C(C(=C2Br)Br)Br)Br)Br
PubChem CID
14410

Risk for babies

Elevated risk

Infants face disproportionate exposure to Decabromodiphenyl ether (DecaBDE / BDE-209) through dust ingestion (hand-to-mouth behavior), breast milk transfer, and dermal contact with treated textiles in cribs and car seats.

Neonates and infants up to 12 months have incomplete blood-brain barrier development, immature Phase I/II metabolic enzymes (particularly CYP3A4, UGT1A1), and higher gastrointestinal permeability. Equivalent doses produce higher internal concentrations and longer residence times.

What to do: Minimize infant exposure through source control. For breastfeeding mothers: reduce maternal exposure. For formula-fed infants: use certified low-migration bottles and verified water sources. Consult pediatrician regarding any concerns.

Risk for pregnant and nursing people

Elevated risk

Prenatal exposure to Decabromodiphenyl ether (DecaBDE / BDE-209) through dust inhalation and dietary intake can affect fetal thyroid function and neurodevelopment. Flame retardants accumulate in breast milk.

Suspected reproductive toxicant (GHS H361) or suspected endocrine disruptor. Precautionary approach warranted. Animal studies or limited human data suggest developmental toxicity potential.

What to do: Minimize exposure during pregnancy and lactation. Consult healthcare provider regarding specific risks. Consider alternative products with lower hazard profiles.

Regulatory consensus

9 regulatory and scientific bodies have classified Decabromodiphenyl ether (DecaBDE / BDE-209). The classifications differ — that's the data.

AgencyYearClassificationNotes
UNEPPersistent Organic Pollutant (POP)
EPA CTX / IRISSuggestive evidence of carcinogenic potential
EPA CTX / IARCGroup 3 - Not classifiable as to its carcinogenicity to humans
EPA CTX / GenetoxGenotoxicity: positive (Ames: negative, 1 positive / 4 negative reports)
EPA CTX / GenetoxGenotoxicity: positive (Ames: negative, 1 positive / 4 negative reports)
EPA CTX / Skin-EyeEye Irritation: Category 2B (score: moderate)
EPA CTX / Skin-EyeSkin Irritation: Category 3 (score: moderate)
EPA CTX / Skin-EyeSkin Sensitization: Not classified (score: low)
EPA CTX / Skin-Eyeeye irritation: in vivo: Studies Indicate No Significant Irritation (score: low)

Regulators apply different standards of evidence — animal-data weighting, exposure-pattern assumptions, epidemiological power thresholds — which is why two scientific bodies can review the same data and reach different conclusions. The disagreement is the data.

Where kids encounter decabromodiphenyl ether (decabde / bde-209)

  • Industrial FacilitiesManufacturing plants, Chemical storage areas, Waste treatment sites
  • Occupational EnvironmentsFactories, Warehouses, Transportation vehicles

Safer alternatives

Lower-risk approaches that achieve a similar outcome to Decabromodiphenyl ether (DecaBDE / BDE-209):

  • Inherently flame-resistant materials (wool, modacrylic, Nomex)
    Trade-offs: Higher material cost. Limited color/texture options.
    Relative cost: 1.2-2×
  • Barrier fabric technology
    Trade-offs: Adds manufacturing step and cost
    Relative cost: 1.2-2×

Frequently asked questions

Is decabromodiphenyl ether (decabde / bde-209) safe for kids?

Infants face disproportionate exposure to Decabromodiphenyl ether (DecaBDE / BDE-209) through dust ingestion (hand-to-mouth behavior), breast milk transfer, and dermal contact with treated textiles in cribs and car seats.

What products contain decabromodiphenyl ether (decabde / bde-209)?

Decabromodiphenyl ether (DecaBDE / BDE-209) appears in: Manufacturing plants (Industrial facilities); Chemical storage areas (Industrial facilities); Factories (Occupational environments); Warehouses (Occupational environments).

What should I do if my child is exposed to decabromodiphenyl ether (decabde / bde-209)?

Minimize infant exposure through source control. For breastfeeding mothers: reduce maternal exposure. For formula-fed infants: use certified low-migration bottles and verified water sources. Consult pediatrician regarding any concerns.

Why do regulators disagree about decabromodiphenyl ether (decabde / bde-209)?

Decabromodiphenyl ether (DecaBDE / BDE-209) has been classified by 9 agencies including UNEP, EPA CTX / IRIS, EPA CTX / IARC, EPA CTX / Genetox, EPA CTX / Genetox, with differing conclusions. Regulators apply different standards of evidence (animal data weighting, exposure-pattern assumptions, epidemiological power thresholds), which is why two scientific bodies can review the same data and reach different conclusions. See the regulatory consensus table on this page for the full picture.

See Decabromodiphenyl ether (DecaBDE / BDE-209) in the baby app

Look up products containing decabromodiphenyl ether (decabde / bde-209), compare to alternatives, and explore the full data record.

Open in baby View raw API data

Sources (2)

  1. Stockholm Convention: Decabromodiphenyl Ether (DecaBDE) Listed under Annex A (Elimination), COP-8 Decision SC-8/12, Debromination Concern, Arctic Contamination, RoHS Interaction, Aircraft Exemptions (2017) (2017) — regulatory
  2. EU Directive 2011/65/EU (RoHS Recast): DecaBDE Restricted in EEE; DecaBDE REACH SVHC Identification; Debromination Products BDE-47/BDE-99 Metabolite Pathway in Humans and Wildlife (2011) (2011) — regulatory

Reference data, not professional advice. Aggregates publicly available regulatory and scientific data; not a substitute for veterinary, medical, legal, or regulatory advice. Why we built ALETHEIA →